Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-534

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 68001-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Bortezomib 01)

Chemical Structure (Bortezomib 01)
FDA Label Image

Figure 1 (Bortezomib 02)

Figure 1 (Bortezomib 02)
FDA Label Image

Figure 2 (Bortezomib 03)

Figure 2 (Bortezomib 03)
FDA Label Image

Figure 3 (Bortezomib 04)

Figure 3 (Bortezomib 04)
FDA Label Image

Figure 4 (Bortezomib 05)

Figure 4 (Bortezomib 05)
This appears to be a table or chart comparing the number of patients remaining at different timepoints for two treatments, Bortezomib and Dexamethasone. The last row indicates a p-value obtained from a statistical test. However, without additional context, it is difficult to interpret what this data represents.*
FDA Label Image

Figure 5 (Bortezomib 06)

Figure 5 (Bortezomib 06)
This appears to be a chart or graph showing the number of patients who received two different treatments, R-CHOP and VcR-CAP, over a period of time measured in months. However, without more contextual information, it is difficult to determine the specifics of the data being presented.*
FDA Label Image

Figure 6 (Bortezomib 07)

Figure 6 (Bortezomib 07)
FDA Label Image

Bortezomib Label (Image 01)

Bortezomib Label (Image 01)
FDA Label Image

Bortezomib Carton (Image 02)

Bortezomib Carton (Image 02)
FDA Label Image

Bortezomib Sticker (Image 03)

Bortezomib Sticker (Image 03)
Bortezomib for Injection is a medication that is administered through subcutaneous and intravenous injection. The final concentration of the solution depends on the amount of 0.9% Sodium Chloride added. The package comes with stickers to label the vial or syringe. The full instructions for usage can be found in the Package Insert under Section 2.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.